Pharmaceutical brand group"Koldact" is designed to combat various inflammatory diseases of the respiratory system. Consider two medicines from this group: "Koldakt Lorkpils" and "Koldakt Broncho".
The medicine "Koldakt Lorpis" is atablets intended for resorption, each of which contains more than one and a half milligrams of alcohol 2,4-dichlorobenzyl, as well as amyl methacrylate. This drug is produced in packages of twenty pieces.
Pharmacological effect of the drug "Koldact"The instructions for use describe this: this drug has antiseptic, analgesic, anti-inflammatory and local anesthetic effects.
Indications for its use in therapyare diseases of the throat cavity, larynx, mouth, having an infectious inflammatory nature: pharyngitis, tonsillitis, laryngitis (including those of a professional nature among workers in the coal, chemical industry, speakers, teachers), hoarseness, thrush, gingivitis, aphthous stomatitis.
Contraindications for the appointment of the drug "Koldact" instructions for use lists such:
- children under five;
hypersensitivity to the components of the drug.
Side effects of this medication are allergic manifestations of different severity.
Dosage and method of application of the drug "Koldact"The instruction manual gives the following. The medicine is taken inwards. For adults, dissolve one piece every two hours until the tablet or lozenge completely dissolves. The maximum permissible daily dose is eight lozenges or tablets. For children, admission (after reaching the age of five) is allowed for one lozenge or tablet every 4 hours.
Specific instructions for the prescription of the medicinal substance "Koldakt" instructions for use lists the following. In the event of skipping at least one or more of the following doses, the following doses are not increased.
Store this medicine in places protected from light, at a temperature of no higher than twenty degrees Celsius for not more than three years.
The drug "Koldakt. Broncho "is a syrup and has an expectorant, antiallergic, vasoconstrictive and mucolytic effect.
The pharmacological effect of this medicationfollowing. The drug is combined and consists of mucolytic ambroxol and guaifenesin, which, liquefying the bronchial secret, facilitate expectoration of sputum. Antiallergic chlorphenamine eliminates tearing and itching of the mucous membranes of the nose and eyes. The drug phenylephrine, narrowing vessels, reduces flushing of the mucous membrane of the paranasal sinuses and respiratory tract.
Indications for the prescription of a medicinal substance"The caging. Broncho "are colds, flu, acute respiratory viral diseases, which are accompanied by a cough with the separation of thick viscous sputum.
Contraindications to the use of medicinalsubstance "Cagedact. Broncho "is the administration of any other medications containing the same active substances, as well as hypersensitivity to its components, convulsive syndrome, cardiac arteriosclerosis, arterial hypertension, thyrotoxicosis, diabetes mellitus, closed angle glaucoma, peptic ulcer and stomach ulcer, hyperplasia prostate.
Doses and the way this medication is used are as follows:it is taken orally, between doses at equal intervals. Prescribe the drug to children who reached the age of twelve, and adults twenty milliliters (or four teaspoons) three times a day, and children from six years to twelve - ten milliliters 2-3 times a day. The course of therapy lasts seven days.
